ALLMedicine™ Movement Disorders Center

May 4th, 2021 - A growing body of evidence suggests Chronic Lower Back Pain (CLBP) is associated with cognitive dysfunction. Little is known, however, about the extent of cognitive impairment in CLBP. The present study explored the cognitive profile of people wit...

May 3rd, 2021 - An Online Education method for Movement disorders during COVID-19: opportunity and experience.|2021|Mahajan A,El-Nazer R,Chitnis S,|

Apr 26th, 2021 - Introduction: Antipsychotic medications are used to treat a number of conditions in children and adolescents. While side effect profiles from second generation antipsychotics (SGAs) may differ from older antipsychotics, they do not come without ri...

Apr 26th, 2021 - Acute presentation of new movement disorders and acute decompensation of chronic movement disorders are uncommon but potentially life-threatening. Inadvertent or purposeful overdose of many psychiatric medications can result in acute life-threaten...

Apr 24th, 2021 - Antibody-mediated encephalitis is a treatable cause of encephalitis that manifests over days to weeks as changes in behavior and cognition, seizures, movement disorders, and autonomic dysfunction. Patients with autoimmune encephalitis develop a va...

May 6th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Oct 8th, 2019 - International Congress of Parkinson’s Disease and Movement Disorders (MDS) 2019: Read clinically focused news coverage of key developments from MDS 2019

Sep 25th, 2019 - On behalf of the International Parkinson and Movement Disorder Society (MDS), we are pleased to welcome you to the International Congress of Parkinson’s Disease and Movement Disorders. Nice is a charming, picturesque city nestled on the southeast ...

Jul 2nd, 2018 - Symptoms of Parkinson’s disease have been controlled with levodopa for many years; however, motor complications consisting of wearing off of medication effect and dyskinesias tend to occur within a few years of starting levodopa. Motor complicatio...

Oct 31st, 2012 - The main results include (1) polysomnography combined with the multiple sleep latency test is useful for evaluating disorders of excessive somnolence to objectively quantify sleepiness. The results have to be interpreted with consideration of the.

May 5th, 2021 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello. I'm Dr Kathrin LaFaver, a movement disorders specialist at Northwestern University here in Chicago. It is my great pleasure today to interview Dr Tamara Pringsheim on the top...

May 4th, 2021 - A growing body of evidence suggests Chronic Lower Back Pain (CLBP) is associated with cognitive dysfunction. Little is known, however, about the extent of cognitive impairment in CLBP. The present study explored the cognitive profile of people wit...

May 3rd, 2021 - An Online Education method for Movement disorders during COVID-19: opportunity and experience.|2021|Mahajan A,El-Nazer R,Chitnis S,|

Apr 26th, 2021 - Introduction: Antipsychotic medications are used to treat a number of conditions in children and adolescents. While side effect profiles from second generation antipsychotics (SGAs) may differ from older antipsychotics, they do not come without ri...

Apr 26th, 2021 - Acute presentation of new movement disorders and acute decompensation of chronic movement disorders are uncommon but potentially life-threatening. Inadvertent or purposeful overdose of many psychiatric medications can result in acute life-threaten...

May 5th, 2021 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello. I'm Dr Kathrin LaFaver, a movement disorders specialist at Northwestern University here in Chicago. It is my great pleasure today to interview Dr Tamara Pringsheim on the top...

Apr 21st, 2021 - SEP-363856, an investigational nondopamine antipsychotic that's been the focus of a trial in schizophrenia, has shown signals that it may improve psychosis symptoms in patients with Parkinson's disease without worsening motor symptoms, according t...

Mar 11th, 2021 - New analyses of both observational and genetic data have provided "convincing evidence" that type 2 diabetes is associated with an increased risk for Parkinson's disease. Dr Alastair Noyce "The fact that we see the same effects in both types of an...

Oct 28th, 2020 - It may be possible to diagnose Parkinson's disease with a skin test, a new study suggests. For the study, researchers used a chemical assay to detect clumping of the protein alpha-synuclein, a hallmark of Parkinson's disease, in autopsy skin sampl...

Sep 20th, 2020 - Adding a low dose of the anti-arrhythmic drug flecainide to modafinil alleviated excessive daytime sleepiness (EDS) in some patients with Parkinson's disease (PD), a new study suggests. "This association may improve wakefulness and cognition proba...